Phoenix Biotech Acquisition Corp. (NASDAQ:PBAX) Sees Large Decline in Short Interest

Phoenix Biotech Acquisition Corp. (NASDAQ:PBAX – Get Rating) was the target of a significant drop in short interest in the month of March. As of March 15th, there was short interest totalling 6,100 shares, a drop of 16.4% from the February 28th total of 7,300 shares. Currently, 0.0% of the company’s stock are sold short. […]

Related Keywords

Phoenix ,Arizona ,United States , ,Phoenix Biotech Acquisition Company Profile ,Phoenix Biotech Acquisition Corp ,Mission Capital ,Nasdaq ,Susquehanna International Group ,Glazer Capital ,Principal Fund ,Phoenix Biotech Acquisition ,Get Rating ,Biotech Acquisition ,Phoenix Biotech Acquisition Daily ,Nasdaq Pbax ,Pbax ,Unclassified ,Stocks ,Options ,Put ,Call ,